Jpmorgan Chase & CO Neovasc Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$6.5 - $16.05 $1,950 - $4,815
-300 Reduced 42.92%
399 $6,000
Q3 2022

Nov 14, 2022
SELL
$5.95 - $7.93 $595 - $793
-100 Reduced 12.52%
699 $5,000
Q2 2022

Aug 11, 2022
BUY
$4.9 - $10.75 $3,915 - $8,589
799 New
799 $5,000

About NEOVASC INC

NVCN Quotes by TradingView
  • Ticker NVCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,743,140
  • Description
  • Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...
More about NVCN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email